Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)
China · Delayed Price · Currency is CNY 21.83
+0.83 (3.95%)
Jun 23, 2026, 3:00 PM CST
SHA:688639 Market Cap
SHA:688639 has a market cap or net worth of 5.24 billion as of June 23, 2026. Its market cap has decreased by -31.08% in one year.
Market Cap
5.24B
Enterprise Value
7.14B
Revenue
2.95B
Ranking
n/a
PE Ratio
42.18
Stock Price
21.83
Market Cap Chart
Since April 22, 2021, SHA:688639's market cap has increased from 3.81B to 5.24B, an increase of 37.57%. That is a compound annual growth rate of 6.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 5.24B | -35.54% |
| Dec 31, 2025 | 8.13B | 10.70% |
| Dec 31, 2024 | 7.34B | -62.99% |
| Dec 29, 2023 | 19.83B | 17.86% |
| Dec 30, 2022 | 16.83B | 20.56% |
| Dec 31, 2021 | 13.96B | 266.67% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Fengbei Biotech Stock | 5.77B |
| Wuhan Keqian Biology Co.,Ltd | 5.70B |
| Hangzhou Biotest Biotech | 5.59B |
| Shanghai OPM Biosciences | 5.30B |
| Jiangsu Aidea Pharmaceutical Group | 5.29B |
| Shanghai Serum Bio-Technology | 5.17B |
| Novogene | 5.06B |
| Shenzhen Weiguang Biological Products | 5.03B |